Search results
Genelux director Mirabelli buys $42,000 in company warrants By Investing.com
Investing.com· 1 day agoDirector of GENELUX Corp (NASDAQ:GNLX), Mary Mirabelli, has made a significant purchase of the...
Tuesday's letters: Problem with weight-loss drugs is their fat price
Greensboro News & Record· 5 days agoWhile I do agree with the title, “Insurance coverage for obesity can allow more to benefit,” I don’t...
Eli Lilly CFO Anat Ashkenazi to resign (NYSE:LLY)
Seeking Alpha· 4 days agoEli Lilly's CFO, Anat Ashkenazi, has resigned after over two decades with the company to explore opportunities outside the pharmaceutical industry.
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
Zacks· 4 days agoThe latest trading session saw Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) ending at $145.97, denoting a -1.24% adjustment from its last day's close. The stock's change was less than ...
Fierce fight with no end in sight for drug discount program - Roll Call
CQ Politics· 6 days agoIn courtrooms and congressional hearing rooms, drug companies and health care providers are waging a...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 2 days agoWhile this analysis focuses on total compensation, it's worth acknowledging that the salary portion...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks· 6 days agoFree Report) ending at $160.19, denoting a -0.65% adjustment from its last day's close. This change lagged the S&P 500's 0.11% gain on the day. In that same time, the Medical sector gained 2.86% ...
House subcommittee lands on transparency for 340B reform
Healthcare Dive via Yahoo Finance· 4 days agoBased on the Oversight and Investigations hearing, political will in Congress seems slim to cut back...
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
Zacks via Yahoo Finance· 3 days agoThis popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG...
Longeveron enters contract manufacturing with Secretome deal By Investing.com
Investing.com· 6 days agoLongeveron Inc. (NASDAQ: LGVN), a biotech company specializing in regenerative medicine, has...